Andrew Dudum, co-founder and CEO of Hims & Hers, said the company could launch an AI health coach within 12 months [1].
The announcement comes as the telehealth company navigates a legal battle with the Federal Trade Commission (FTC) over its business practices. The integration of artificial intelligence into patient care represents a shift toward automated medication adherence and personalized health management.
During an appearance on CNBC's "Squawk Box," Dudum said the impact of AI on the healthcare industry is "transformative" [2]. He said the upcoming AI health coach is intended to help patients stay consistent with their treatments, which he believes will increase overall medication adherence [1].
Beyond technological expansions, Dudum used the interview to address the ongoing FTC lawsuit. He said the agency's legal action reflects a misunderstanding of how Hims & Hers operates [3]. He said the company is "active disruptors" in a healthcare system that often struggles with affordability and accessibility [4].
Dudum spoke about the company's broader strategy to lower healthcare costs for consumers. This effort includes the use of AI to streamline processes, and the offering of GLP-1 drugs to expand weight loss treatment options [5].
The CEO said that the company's goal is to challenge traditional healthcare delivery models. By combining digital interfaces with AI-driven tools, Hims & Hers aims to reduce the friction patients experience when seeking prescriptions and medical advice [5].
“"It's transformative."”
The push toward AI-driven health coaching signals a move by telehealth providers to move beyond simple prescription fulfillment toward longitudinal patient management. However, the simultaneous legal pressure from the FTC suggests a tension between the rapid disruption of healthcare delivery and the regulatory frameworks governing patient safety and consumer protection.
